Laboratory Corporation of America Holdings LAB.F Stock
Laboratory Corporation of America Holdings Price Chart
Laboratory Corporation of America Holdings LAB.F Financial and Trading Overview
Contents
- Laboratory Corporation of America Holdings Price Chart
- Laboratory Corporation of America Holdings LAB.F Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Laboratory Corporation of America Holdings
- Q&A For Laboratory Corporation of America Holdings Stock
Laboratory Corporation of America Holdings stock price | 192 EUR |
Previous Close | 208 EUR |
Open | 210 EUR |
Bid | 210 EUR x 10000 |
Ask | 212 EUR x 10000 |
Day's Range | 210 - 210 EUR |
52 Week Range | 196 - 256 EUR |
Volume | 35 EUR |
Avg. Volume | 0 EUR |
Market Cap | 18.61B EUR |
Beta (5Y Monthly) | 1.042253 |
PE Ratio (TTM) | 19.924099 |
EPS (TTM) | 4.03 EUR |
Forward Dividend & Yield | 2.69 (1.28%) |
Ex-Dividend Date | May 17, 2023 |
1y Target Est | 334.29 EUR |
LAB.F Valuation Measures
Enterprise Value | 24.77B EUR |
Trailing P/E | 19.924099 |
Forward P/E | 12.758203 |
PEG Ratio (5 yr expected) | -1.32 |
Price/Sales (ttm) | 1.2609878 |
Price/Book (mrq) | 1.7991621 |
Enterprise Value/Revenue | 1.679 |
Enterprise Value/EBITDA | 10.685 |
Trading Information
Laboratory Corporation of America Holdings Stock Price History
Beta (5Y Monthly) | 1.042253 |
52-Week Change | 2.02% |
S&P500 52-Week Change | 20.43% |
52 Week High | 256 EUR |
52 Week Low | 196 EUR |
50-Day Moving Average | 204.27 EUR |
200-Day Moving Average | 218.87 EUR |
LAB.F Share Statistics
Avg. Volume (3 month) | 0 EUR |
Avg. Daily Volume (10-Days) | 3 EUR |
Shares Outstanding | 88.6M |
Float | 88.3M |
Short Ratio | N/A |
% Held by Insiders | 0.27% |
% Held by Institutions | 93.05% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 2.88 |
Trailing Annual Dividend Yield | 1.38% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.2588 |
Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 6.78% |
Operating Margin (ttm) | 12.03% |
Gross Margin | 27.96% |
EBITDA Margin | 15.70% |
Management Effectiveness
Return on Assets (ttm) | 5.42% |
Return on Equity (ttm) | 9.49% |
Income Statement
Revenue (ttm) | 14.76B EUR |
Revenue Per Share (ttm) | 164.13 EUR |
Quarterly Revenue Growth (yoy) | -3.10% |
Gross Profit (ttm) | 4.39B EUR |
EBITDA | 2.32B EUR |
Net Income Avi to Common (ttm) | 1B EUR |
Diluted EPS (ttm) | 10.54 |
Quarterly Earnings Growth (yoy) | -56.69% |
Balance Sheet
Total Cash (mrq) | 393.9M EUR |
Total Cash Per Share (mrq) | 4.45 EUR |
Total Debt (mrq) | 6.36B EUR |
Total Debt/Equity (mrq) | 61.37 EUR |
Current Ratio (mrq) | 1.627 |
Book Value Per Share (mrq) | 116.721 |
Cash Flow Statement
Operating Cash Flow (ttm) | 1.72B EUR |
Levered Free Cash Flow (ttm) | 970.19M EUR |
Profile of Laboratory Corporation of America Holdings
Country | Germany |
State | NC |
City | Burlington |
Address | 358 South Main Street |
ZIP | 27215 |
Phone | 336 229 1127 |
Website | https://www.labcorp.com |
Industry | Diagnostics & Research |
Sector(s) | Healthcare |
Full Time Employees | 80000 |
Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics and Labcorp Drug Development. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. In addition, the company offers online and mobile applications to enable patients to check test results; and online applications for MCOs and accountable care organizations; and end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves MCOs, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.
Q&A For Laboratory Corporation of America Holdings Stock
What is a current LAB.F stock price?
Laboratory Corporation of America Holdings LAB.F stock price today per share is 192 EUR.
How to purchase Laboratory Corporation of America Holdings stock?
You can buy LAB.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Laboratory Corporation of America Holdings?
The stock symbol or ticker of Laboratory Corporation of America Holdings is LAB.F.
Which industry does the Laboratory Corporation of America Holdings company belong to?
The Laboratory Corporation of America Holdings industry is Diagnostics & Research.
How many shares does Laboratory Corporation of America Holdings have in circulation?
The max supply of Laboratory Corporation of America Holdings shares is 84.13M.
What is Laboratory Corporation of America Holdings Price to Earnings Ratio (PE Ratio)?
Laboratory Corporation of America Holdings PE Ratio is 47.64267700 now.
What was Laboratory Corporation of America Holdings earnings per share over the trailing 12 months (TTM)?
Laboratory Corporation of America Holdings EPS is 4.03 EUR over the trailing 12 months.
Which sector does the Laboratory Corporation of America Holdings company belong to?
The Laboratory Corporation of America Holdings sector is Healthcare.